Bedell Frazier Investment Counselling’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$678K	Sell	3,376 -121	-3%	-$25K	0.14%	80
2025 Q4	$722K	Buy	3,497 +297	+9%	+$59.3K	0.14%	82
2025 Q3	$574K	Buy	3,200 +57	+2%	+$9.71K	0.12%	89
2025 Q2	$507K	Sell	3,143 -2,658	-46%	-$423K	0.13%	78
2025 Q1	$987K	Sell	5,801 -26	-0.4%	-$4.51K	0.25%	58
2024 Q4	$969K	Buy	5,827 +15	+0.3%	+$2.56K	0.24%	60
2024 Q3	$999K	Sell	5,812 -3,560	-38%	-$589K	0.24%	60
2024 Q2	$1.44M	Sell	9,372 -179	-2%	-$26.9K	0.35%	58
2024 Q1	$1.47M	Sell	9,551 -388	-4%	-$59.2K	0.37%	57
2023 Q4	$1.57M	Buy	9,939 +3,586	+56%	+$515K	0.43%	49
2023 Q3	$930K	Buy	6,353 +420	+7%	+$64K	0.28%	55
2023 Q2	$909K	Sell	5,933 -334	-5%	-$52.1K	0.27%	56
2023 Q1	$972K	Sell	6,267 -339	-5%	-$53.2K	0.28%	51
2022 Q4	$1.02M	Buy	6,606 +1,235	+23%	+$182K	0.27%	59
2022 Q3	$709K	Buy	5,371 +1,171	+28%	+$164K	0.2%	63
2022 Q2	$569K	Sell	4,200 -414	-9%	-$57.1K	0.17%	53
2022 Q1	$688K	Sell	4,614 -30	-0.6%	-$4.44K	0.17%	60
2021 Q4	$752K	Sell	4,644 -250	-5%	-$40.4K	0.18%	66
2021 Q3	$813K	Sell	4,894 -22	-0.4%	-$3.76K	0.22%	56
2021 Q2	$849K	Buy	4,916 +106	+2%	+$17.5K	0.22%	61
2021 Q1	$772K	Sell	4,810 -17	-0.4%	-$2.91K	0.22%	57
2020 Q4	$811K	Sell	4,827 -168	-3%	-$27.3K	0.25%	55
2020 Q3	$786K	Sell	4,995 -25	-0.5%	-$4.09K	0.28%	50
2020 Q2	$842K	Sell	5,020 -100	-2%	-$15.7K	0.34%	44
2020 Q1	$671K	Buy	5,120 +275	+6%	+$39.2K	0.31%	38
2019 Q4	$600K	Hold	4,845	–	–	0.24%	37
2019 Q3	$600K	Sell	4,845 -30	-0.6%	-$3.99K	0.23%	39
2019 Q2	$687K	Sell	4,875 -5	-0.1%	-$690	0.25%	37
2019 Q1	$736K	Sell	4,880 -405	-8%	-$58.3K	0.29%	37
2018 Q4	$656K	Sell	5,285 -105	-2%	-$14.4K	0.28%	34
2018 Q3	$854K	Sell	5,390 -330	-6%	-$49.9K	0.24%	43
2018 Q2	$801K	Buy	5,720 +40	+0.7%	+$5.49K	0.23%	41
2018 Q1	$755K	Buy	+5,680	New	+$775K	0.27%	37
2017 Q2	–	Sell	-5,995	Closed	-$631K	–	45
2017 Q1	$631K	Sell	5,995 -125	-2%	-$12.5K	0.24%	35
2016 Q4	$556K	Buy	+6,120	New	+$573K	0.22%	41
2015 Q4	–	Sell	-11,760	Closed	-$1.19M	–	54
2015 Q3	$1.19M	Buy	+11,760	New	+$1.4M	0.69%	30
2015 Q1	–	Sell	-12,242	Closed	-$1.25M	–	75
2014 Q4	$1.25M	Sell	12,242 -300	-2%	-$29.3K	0.61%	39
2014 Q3	$1.15M	Buy	+12,542	New	+$1.09M	0.54%	39
2014 Q1	–	Sell	-16,132	Closed	-$1.12M	–	53
2013 Q4	$1.12M	Sell	16,132 -375	-2%	-$24.6K	0.52%	43
2013 Q3	$1.07M	Buy	16,507 +280	+2%	+$17.7K	0.51%	42
2013 Q2	$1M	Buy	+16,227	New	+$927K	0.5%	43

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Bedell Frazier Investment Counselling's FBT Position: Q1 2026 in Review

Bedell Frazier Investment Counselling reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.5% in Q1 2026, selling an estimated $25K and leaving 3,376 shares worth $678K. The position accounts for 0.14% of the portfolio, ranked #80.

Bedell Frazier Investment Counselling first reported a position in FBT in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.57M in Q4 2023. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Bedell Frazier Investment Counselling held 3,376 shares of First Trust NYSE Arca Biotechnology Index Fund worth $678K as of Q1 2026.
Bedell Frazier Investment Counselling sold 121 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $25K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.14% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #80 holding.
Bedell Frazier Investment Counselling first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 41 quarters since.
Bedell Frazier Investment Counselling's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.57M in Q4 2023.
308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.